Evidence for efficacy is based on the results from the ASC4FIRST study
Home World News FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid Leukaemia
Evidence for efficacy is based on the results from the ASC4FIRST study
